Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

20小时前 1e227a5em69(暂无匿称)

请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-04-27 ms6000002977722155 来自上海

JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。
整体较快，平均1-3个月完成审稿。
文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。
格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。

10 0

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-04-12 1442866843 来自湖南省

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤学
经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-02-14 ms4000001757914888 来自辽宁

偏重的研究方向：肿瘤
经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的

23 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-03-13 prosperli 来自广东省

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：外科;结直肠癌
经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-02-15 要没时间了来自辽宁省

偏重的研究方向：肿瘤
经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢

23 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-01-09 ms8000000124135786

多久才能pubmed检索啊

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2025-01-13 shademei 来自山西省

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2024-12-23 ms1000000382468845 来自重庆

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2266079, encodeId=9fba22660e938, content=请问有没有遇到版面费支付完后在invoice可以看到已支付，但是在submission还是显示unpaid，一般付款后几天能显示已支付呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=67dd2027216, createdName=1e227a5em69(暂无匿称), createdTime=Wed May 21 21:14:22 CST 2025, time=20小时前, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2262558, encodeId=fc282262558ae, content=JCR Q2，中科院医学大类3区，覆盖癌症生物学、免疫治疗、外科手术、基因组学等方向，尤其重视基础与临床研究的结合。期刊对国人友好，2022-2023年国人发文占比超56%，位居第一。 整体较快，平均1-3个月完成审稿。 文章类型：以Article（69.88%）和Review（24.69%）为主，病例报告需严格遵循CARE指南并获取患者知情同意。 格式要求：英语撰写，重复率≤10%，参考文献≥25条（近5年占比50%+），图表分辨率≥300dpi。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms6000002977722155, createdTime=Sun Apr 27 23:19:55 CST 2025, time=2025-04-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2260115, encodeId=d34e2260115b6, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤学 经验分享：2024年10月底投稿，外审大概2个月，修改一次后在2025年2月底就接收，2025年3月初发表，投稿的是一篇证据总结，我觉得还挺快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d15e4714042, createdName=1442866843, createdTime=Sat Apr 12 09:46:11 CST 2025, time=2025-04-12, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251961, encodeId=c36622519616a, content=偏重的研究方向：肿瘤 经验分享：第二次投了，妇科肿瘤方向，17天了仍是Editorial Assignment状态，副编辑仍未分配，朋友们你们的也这么慢吗？是杂志整体变慢了吗？我记得第一次的时候蛮快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c00d8129740, createdName=ms4000001757914888, createdTime=Fri Feb 14 19:13:46 CST 2025, time=2025-02-14, status=1, ipAttribution=辽宁), GetPortalCommentsPageByObjectIdResponse(id=2255948, encodeId=5ac5225594847, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：外科;结直肠癌 经验分享：结直肠癌外科手术方面的小文章，编辑速度很快，2个小修，2周修回，再1周接收。比较担心被预警。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/4oGJanAwYP71kBMib4MbsUH6DlDZThuRKQkJ1ibJkzuurhSJZ4zcxZPBQYr2OLZdl3dkfq351dJ9kWv5pCZmjLPg/132, createdBy=c2c22368859, createdName=prosperli, createdTime=Thu Mar 13 19:16:27 CST 2025, time=2025-03-13, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2252015, encodeId=9c2322520150a, content=偏重的研究方向：肿瘤 经验分享：投了一篇Meta，顺利接收，时间线如下： Received date: 16 Jan 2025 Editorial assignment start date: 16 Jan 2025 Independent review start date: 18 Jan 2025 Interactive review activated date: 26 Jan 2025 Review finalized date: 10 Feb 2025 Final validation date: 13 Feb 2025 感谢大家的经验分享，受益良多，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DSKSsTZWSAHzbu47LXNPxMa56rEEsmGbA6TZOLicSdqXhIJT8tce14ZrGYB0p0LPAKzZyVUUstj63e7UzvYT9ew/132, createdBy=1dff2428106, createdName=要没时间了, createdTime=Sat Feb 15 09:57:36 CST 2025, time=2025-02-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京)]

2024-01-01 ms4000001668897773 来自北京

偏重的研究方向：肿瘤
经验分享：23.12.27 submit 24.1.1 仍然initial validation

127 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务